Incidental Mutation 'R0583:Tatdn2'
ID 56504
Institutional Source Beutler Lab
Gene Symbol Tatdn2
Ensembl Gene ENSMUSG00000056952
Gene Name TatD DNase domain containing 2
Synonyms mKIAA0218
MMRRC Submission 038773-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R0583 (G1)
Quality Score 181
Status Not validated
Chromosome 6
Chromosomal Location 113674090-113688030 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 113679486 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Glutamic Acid to Glycine at position 277 (E277G)
Ref Sequence ENSEMBL: ENSMUSP00000145308 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000089018] [ENSMUST00000113022] [ENSMUST00000153661] [ENSMUST00000204753]
AlphaFold B7ZNL9
Predicted Effect probably benign
Transcript: ENSMUST00000089018
AA Change: E277G

PolyPhen 2 Score 0.018 (Sensitivity: 0.95; Specificity: 0.80)
SMART Domains Protein: ENSMUSP00000086412
Gene: ENSMUSG00000056952
AA Change: E277G

DomainStartEndE-ValueType
low complexity region 63 95 N/A INTRINSIC
low complexity region 237 255 N/A INTRINSIC
low complexity region 382 392 N/A INTRINSIC
Pfam:TatD_DNase 457 721 3.3e-59 PFAM
Predicted Effect possibly damaging
Transcript: ENSMUST00000113022
AA Change: E277G

PolyPhen 2 Score 0.795 (Sensitivity: 0.85; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000108645
Gene: ENSMUSG00000056952
AA Change: E277G

DomainStartEndE-ValueType
low complexity region 63 95 N/A INTRINSIC
low complexity region 237 255 N/A INTRINSIC
low complexity region 443 453 N/A INTRINSIC
Pfam:TatD_DNase 518 782 3.7e-61 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000138420
SMART Domains Protein: ENSMUSP00000116559
Gene: ENSMUSG00000056952

DomainStartEndE-ValueType
Pfam:TatD_DNase 1 146 2.9e-38 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000153661
SMART Domains Protein: ENSMUSP00000123557
Gene: ENSMUSG00000056952

DomainStartEndE-ValueType
Pfam:TatD_DNase 1 122 1.3e-22 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000200187
Predicted Effect possibly damaging
Transcript: ENSMUST00000204753
AA Change: E277G

PolyPhen 2 Score 0.795 (Sensitivity: 0.85; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000145308
Gene: ENSMUSG00000056952
AA Change: E277G

DomainStartEndE-ValueType
low complexity region 63 95 N/A INTRINSIC
low complexity region 237 255 N/A INTRINSIC
low complexity region 443 453 N/A INTRINSIC
Pfam:TatD_DNase 518 782 3.7e-61 PFAM
Coding Region Coverage
  • 1x: 99.4%
  • 3x: 98.8%
  • 10x: 97.1%
  • 20x: 93.2%
Validation Efficiency
Allele List at MGI
Other mutations in this stock
Total: 52 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1700017B05Rik A G 9: 57,164,926 (GRCm39) S483P probably benign Het
5730480H06Rik A G 5: 48,537,470 (GRCm39) H169R probably damaging Het
Actn1 T A 12: 80,245,803 (GRCm39) I127F probably damaging Het
Cadm3 T G 1: 173,168,738 (GRCm39) T277P probably benign Het
Cast T C 13: 74,861,797 (GRCm39) T629A probably damaging Het
Cblc C A 7: 19,526,486 (GRCm39) C201F probably benign Het
Ccdc154 T A 17: 25,387,398 (GRCm39) D375E possibly damaging Het
Cdk6 A G 5: 3,523,183 (GRCm39) D201G probably damaging Het
Cep95 T C 11: 106,705,449 (GRCm39) V478A probably benign Het
Ciita T C 16: 10,341,668 (GRCm39) probably null Het
Clec4e A G 6: 123,260,653 (GRCm39) F135S probably damaging Het
Cntn6 A G 6: 104,753,275 (GRCm39) D337G possibly damaging Het
Crlf3 A T 11: 79,950,107 (GRCm39) H174Q probably damaging Het
Cyb5r1 T A 1: 134,335,339 (GRCm39) F93I probably damaging Het
Dop1b T C 16: 93,552,374 (GRCm39) I271T probably benign Het
Duxf1 G A 10: 58,059,210 (GRCm39) L515F probably damaging Het
Fcho1 T C 8: 72,168,369 (GRCm39) Y218C probably damaging Het
Fhad1 C T 4: 141,631,301 (GRCm39) M1297I probably benign Het
Igdcc4 T C 9: 65,029,095 (GRCm39) V244A possibly damaging Het
Ikzf5 A G 7: 130,993,514 (GRCm39) probably null Het
Ilvbl T A 10: 78,419,101 (GRCm39) V450E probably damaging Het
Kcns3 T G 12: 11,141,479 (GRCm39) N407H probably damaging Het
Klhl11 T C 11: 100,355,150 (GRCm39) K224E possibly damaging Het
Klra17 T A 6: 129,845,656 (GRCm39) D186V probably damaging Het
Lrrc37a T C 11: 103,389,263 (GRCm39) D2054G probably benign Het
Mef2a G T 7: 66,884,896 (GRCm39) S406* probably null Het
Mrgbp A G 2: 180,226,239 (GRCm39) N104S probably benign Het
Mroh2a GT GTT 1: 88,183,888 (GRCm39) probably null Het
Muc5ac C A 7: 141,361,345 (GRCm39) T1552N probably damaging Het
Muc5b T A 7: 141,410,435 (GRCm39) Y1269* probably null Het
Myef2 T C 2: 124,939,901 (GRCm39) probably null Het
Myg1 C T 15: 102,246,225 (GRCm39) Q367* probably null Het
Nalcn T C 14: 123,531,755 (GRCm39) N1365S possibly damaging Het
Nfu1 T C 6: 86,986,934 (GRCm39) C18R probably benign Het
Nkx2-6 A T 14: 69,412,228 (GRCm39) Q132L probably damaging Het
Or10a3b C T 7: 108,444,621 (GRCm39) A199T possibly damaging Het
Or8k38 T A 2: 86,488,704 (GRCm39) I33F probably benign Het
Pak3 TTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTC TTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTC X: 142,526,889 (GRCm39) probably benign Het
Prh1 A T 6: 132,548,796 (GRCm39) Q101L unknown Het
Ribc2 A T 15: 85,017,115 (GRCm39) probably null Het
Rnf19a C A 15: 36,253,151 (GRCm39) R396L probably damaging Het
Sdad1 A G 5: 92,452,923 (GRCm39) I105T probably damaging Het
Sec24b G T 3: 129,834,960 (GRCm39) Y79* probably null Het
Tex10 A C 4: 48,451,952 (GRCm39) F725V probably damaging Het
Themis3 T C 17: 66,866,748 (GRCm39) D164G probably benign Het
Ubxn7 T C 16: 32,194,732 (GRCm39) W220R probably damaging Het
Usp33 C A 3: 152,073,891 (GRCm39) R246S probably damaging Het
Vmn2r102 T A 17: 19,897,043 (GRCm39) V130E probably benign Het
Vmn2r112 C T 17: 22,837,930 (GRCm39) P797L probably damaging Het
Vmn2r114 ATTT ATT 17: 23,509,906 (GRCm39) probably null Het
Yme1l1 T C 2: 23,076,262 (GRCm39) V340A probably damaging Het
Zfta A G 19: 7,397,639 (GRCm39) D62G probably damaging Het
Other mutations in Tatdn2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01302:Tatdn2 APN 6 113,680,985 (GRCm39) splice site probably benign
IGL01335:Tatdn2 APN 6 113,681,017 (GRCm39) missense probably benign 0.29
IGL01459:Tatdn2 APN 6 113,686,992 (GRCm39) splice site probably null
IGL02406:Tatdn2 APN 6 113,681,174 (GRCm39) missense probably benign 0.41
IGL02728:Tatdn2 APN 6 113,681,676 (GRCm39) missense probably damaging 1.00
R0321:Tatdn2 UTSW 6 113,686,462 (GRCm39) missense probably damaging 1.00
R0506:Tatdn2 UTSW 6 113,679,550 (GRCm39) missense probably benign 0.13
R1022:Tatdn2 UTSW 6 113,686,506 (GRCm39) missense probably damaging 1.00
R1024:Tatdn2 UTSW 6 113,686,506 (GRCm39) missense probably damaging 1.00
R1301:Tatdn2 UTSW 6 113,681,076 (GRCm39) missense probably damaging 1.00
R1454:Tatdn2 UTSW 6 113,681,288 (GRCm39) missense probably benign 0.26
R1459:Tatdn2 UTSW 6 113,687,031 (GRCm39) missense probably damaging 1.00
R1710:Tatdn2 UTSW 6 113,674,888 (GRCm39) missense possibly damaging 0.90
R1771:Tatdn2 UTSW 6 113,679,060 (GRCm39) critical splice acceptor site probably null
R2064:Tatdn2 UTSW 6 113,681,103 (GRCm39) missense probably benign 0.41
R2065:Tatdn2 UTSW 6 113,681,103 (GRCm39) missense probably benign 0.41
R2067:Tatdn2 UTSW 6 113,681,103 (GRCm39) missense probably benign 0.41
R4446:Tatdn2 UTSW 6 113,679,501 (GRCm39) critical splice donor site probably null
R4654:Tatdn2 UTSW 6 113,684,326 (GRCm39) missense probably benign 0.09
R4888:Tatdn2 UTSW 6 113,681,566 (GRCm39) missense possibly damaging 0.66
R7378:Tatdn2 UTSW 6 113,681,662 (GRCm39) missense probably damaging 1.00
R7971:Tatdn2 UTSW 6 113,687,235 (GRCm39) splice site probably null
R8086:Tatdn2 UTSW 6 113,686,482 (GRCm39) missense probably damaging 1.00
R8833:Tatdn2 UTSW 6 113,684,348 (GRCm39) missense probably damaging 1.00
R8872:Tatdn2 UTSW 6 113,681,170 (GRCm39) missense probably damaging 1.00
R9186:Tatdn2 UTSW 6 113,687,125 (GRCm39) missense probably benign 0.13
R9234:Tatdn2 UTSW 6 113,679,683 (GRCm39) critical splice donor site probably null
Predicted Primers PCR Primer
(F):5'- CCTCAAGACCAGGGCTCAAGAATG -3'
(R):5'- GGGCTGGAGAGGGTTTGTCAATAAC -3'

Sequencing Primer
(F):5'- AAGCTTGGGAGACTGTCCTAATC -3'
(R):5'- AGAGGGTTTGTCAATAACTGTCC -3'
Posted On 2013-07-11